Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Croscarmellose Sodium

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Croscarmellose Sodium

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of February 14, 2024
    Enforcement Report - Week of February 14, 2024

    14 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-14-2024-75684.pdf

    FDA
    14 Feb 2024
    Share Share
    Enforcement Report - Week of November 29, 2023
    Enforcement Report - Week of November 29, 2023

    29 Nov 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-29-2023-18805.pdf

    FDA
    29 Nov 2023
    Share Share
    Enforcement Report - Week of July 19, 2023
    Enforcement Report - Week of July 19, 2023

    19 Jul 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-19-2023-37838.pdf

    FDA
    19 Jul 2023
    Share Share
    Global Pharma Healthcare Issues Voluntary Nationwide Recall of Artificial Tears Lubricant Eye Drops Due to Possible Contamination
    Global Pharma Healthcare Issues Voluntary Nationwide Recall of Artificial Tears Lubricant Eye Drops Due to Possible Contamination

    02 Feb 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/global-pharma-healthcare-issues-voluntary-nationwide-recall-of-artificial-tears-lubricant-eye-drops-due-to-possible-contamination-21589.pdf

    FDA
    02 Feb 2023
    Share Share
    Enforcement Report - Week of September 29, 2021
    Enforcement Report - Week of September 29, 2021

    29 Sep 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-29-2021-1632907538.pdf

    FDA
    29 Sep 2021
    Share Share